
Philip M Robson, PhD
About Me
Dr. Robson is an Instructor of Radiology in the BioMedical Engineering and Imaging Institute (BMEII) and is a member of the Cardiovascular Imaging group. Dr. Robson’s research includes the development of hybrid positron emission tomography (PET) magnetic resonance (MR) imaging technology and its applications in cardiovascular disease, including coronary and carotid artery disease, cardiac sarcoidosis and other cardiomyopathies. His work has led to some of the first successful applications of imaging the activity of micro-calcification and inflammation in atherosclerotic plaque in the coronary arteries using 18F-fluoride and 18F-FDG PET/MR imaging and the development of combined PET and MR protocols for evaluating cardiac sarcoidosis and amyloidosis. He is currently working on methods for MR-based motion correction of PET data, MR-based attenuation correction and complementary anatomical and functional cardiac MR imaging for optimizing cardiac and coronary PET/MR imaging. Dr. Robson’s research includes partnerships with clinical investigators in the Cardiovascular Institute as well as national and international collaborators. Before joining Mount Sinai, Dr. Robson worked as a postdoctoral fellow at Beth Israel Deaconess Medical Center and Harvard Medical School in Boston, MA. He was awarded doctoral and undergraduate degrees in Physics by the University of Cambridge, UK.
Language
English
Position
INSTRUCTOR | Diagnostic, Molecular and Interventional Radiology
Research Topics
Atherosclerosis, Cardiovascular, Imaging, MRI, Magnetic Resonance Imaging, Positron Emission Tomography
Education
MSci / BA, University of Cambridge
PhD, University of Cambridge
Publications
Selected Publications
- Streamlined calculation of kidney function using dynamic contrast-enhanced MRI with population-based arterial input function and a whole-kidney model. Xin Mu, Mira M. Liu, Haitham Al-Mubarak, Paul Kennedy, Philip Robson, Jordan Cuevas, Bernd Kuhn, Ketan Badani, Bachir Taouli, Sara Lewis, Octavia Bane. European radiology experimental
- Corrigendum to ‘Anomalous Attachment of the Posterior Mitral Annulus to the Crest of the Left Ventricle in Patients with Mitral Annular Disjunction (MAD) and Mitral Valve Prolapse’[The American Journal of Cardiology 263 (2026) 27-32]. Jeffrey J. Silbiger, Oksana Marchenko, Raveen Bazaz, Priya Panday, Aviv Alter, Pedro Rafael Vieira De Olivera Salerno, Philip Robson, Marc Miller, Zahi Fayad, Maria Giovanna Trivieri. American Journal of Cardiology
- Sarcoidosis Masquerading as Hypertrophic Cardiomyopathy. Sanjay Sivalokanathan, Sharan J. Kapadia, Philip Robson, Zahi Fayad, Adam Jacobi, Anuradha Lala, Sean Pinney, Valentin Fuster, Maria Giovanna Trivieri. JACC: Case Reports
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Robson has not yet completed reporting of industry relationships or has no industry relationships to report.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.